Asep Medical Holdings Inc
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SEPSF research report →
About the company
Asep Medical Holdings Inc. , operating primarily through its subsidiary ASEP Medical Inc. , is dedicated to advancing both a rapid diagnostic system for Sepsis and a range of peptide-based therapeutic treatments applicable across various medical conditions.
- CEO
- Richard Heinzl
- IPO
- 2022
- Employees
- 6
- HQ
- Vancouver, BC, CA
Price Chart
- Market Cap
- $121.25K
- P/E
- -0.98
- P/S
- 68.41
- P/B
- 0.64
- EV/EBITDA
- -0.17
- Div Yield
- 0.00%
- Gross Margin
- -538.03%
- Op Margin
- -36524.42%
- Net Margin
- -38918.30%
- ROE
- -58.60%
- ROIC
- -31.34%
- Revenue
- $336.50K · 0.00%
- Net Income
- $-4,911,857 · 0.00%
- EPS
- $-0.48 · 0.00%
- Op Income
- $-2,562,000
- FCF YoY
- 0.00%
- 52W High
- $0.39
- 52W Low
- $0.01
- 50D MA
- $0.01
- 200D MA
- $0.08
- Beta
- -1.08
- Avg Volume
- 6.52K
Get TickerSpark's AI analysis on SEPSF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our SEPSF coverage
Recent articles, reports, and earnings notes.
No research on SEPSF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SEPSF report →Similar companies
Peers in the same neighborhood.